Gabriel K. Griffin
机构:Broad Institute, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute · ORCID:0009-0006-0185-1239
发表论文 119 篇 · 总被引 8064 次 · h-index 25
代表论文
- The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity (2023 · Nature · 被引 189)
- Sensitivity to targeted UBA1 inhibition in a myeloid cell line model of VEXAS syndrome (2023 · Blood Advances · 被引 23)
- Human Plasma Proteomic Profile of Clonal Hematopoiesis (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 5)
- Integrative cytogenetic and molecular studies unmask “chromosomal mimicry” in hematologic malignancies (2025 · Blood Advances · 被引 4)
- A Novel BCR::ABL1 Rearrangement Harboring the Gatekeeper Mutation Drives Hyper-Kinase Activity Conferring Resistance to Ponatinib and Asciminib Combination Therapy (2024 · Blood · 被引 4)
- Sensitivity to Targeted UBA1 Inhibition in a Myeloid Cell Line Model of Vexas Syndrome (2023 · Blood · 被引 2)